Objective:
To address the recognition and treatment of ocular rosacea in patients with darker skin tones, highlighting the differences in presentation and treatment protocols, particularly regarding safety and efficacy.
Key Findings:
- Ocular rosacea is underrecognized in darker skin tones due to subtle presentation, impacting treatment efficacy.
- Common manifestations include eyelid telangiectasia, postinflammatory hyperpigmentation, and minimal visible redness, which complicate diagnosis.
- IPL combined with meibomian gland expression yields superior results compared to either treatment alone, highlighting the need for tailored approaches.
Interpretation:
The findings underscore the importance of tailored treatment approaches and increased education for healthcare providers regarding ocular rosacea in darker skin tones.
Limitations:
- Lack of representation of darker skin tones in epidemiologic studies and clinical trials.
- Potential for underdiagnosis due to subtle clinical signs.
- Need for more diverse clinical trials to improve treatment protocols.
Conclusion:
Customized treatment protocols and increased awareness among healthcare providers are essential for effectively managing ocular rosacea in patients with darker skin tones.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
